Health Care M&A Transactions in Japan

He has handled more than 200 M&A deals for listed and private companies, both in Japan and overseas, by utilizing his practical experience obtained in the United States, which has allowed him to establish a strong reputation in the fields of business revitalization, bankruptcy, and litigation. He also deals with a wide variety of projects, which range from startup acquisitions to tender offer deals. In the field of disputes, he mainly deals with large and complex proceedings, and also has experience in international arbitration and mediation. Since he counts a large number of listed companies and universities as his clients and also serves as an outside director/auditor of various listed companies, he has been heavily involved in businesses run by manufacturers and retailers, as well as those in the healthcare industry and real estate industry, and those related to IT, human resources, and the operation of universities. He has accumulated a wealth of legal knowledge and experience and advises clients on a wide range of legal topics, including corporate law, commercial law, personnel and labor law, intellectual property, and antitrust.

Yoko’s practice focuses on representation of life sciences and technology companies that develop and market pharmaceuticals, biologics, vaccines, diagnostics, medical devices, and digital health products. She specializes in corporate transactions involving complex intellectual property and pharmaceutical regulatory issues, including mergers and acquisitions, joint ventures, strategic alliances and asset transfers. In addition, she counsels clients on matters involving research and development collaborations, clinical trials, technology licensing, supply and distribution agreements, and co-promotion arrangements. She also advises clients in connection with privacy and personal data protection matters.